5//SEC Filing
Linde North America, Inc. 5
Accession 0000950157-18-000023
CIK 0001600132other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 1:39 PM ET
Size
10.9 KB
Accession
0000950157-18-000023
Insider Transaction Report
Form 5
Linde North America, Inc.
10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2016-11-29+1,920,000→ 1,920,000 totalExercise: $0.80Exp: 2021-11-29→ Common Stock (1,920,000 underlying) - Purchase
Common Stock
2016-11-29+1,920,000→ 5,271,796 total - Purchase
Common Stock Warrants (right to buy)
2017-09-29+1,721,992→ 1,721,992 totalExercise: $1.24Exp: 2022-09-29→ Common Stock (1,721,992 underlying) - Purchase
Common Stock
2017-09-29+1,721,992→ 5,271,796 total
Footnotes (4)
- [F1]The reported securities are included within Units purchased by the reporting person for $0.70 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- [F2]The reported securities are included within Units purchased by the reporting person for $1.205 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.
- [F3]The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
- [F4]The warrants to purchase shares of common stock are currently not exercisable by Linde North America, Inc. due to the exercise limitations of the warrants.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001505451
Filing Metadata
- Form type
- 5
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 1:39 PM ET
- Size
- 10.9 KB